Patents Assigned to Licestia Ltd.
  • Ret-independent signaling pathway for GDNF
    Patent number: 6905817
    Abstract: Methods for screening for agonists and antagonists of GPI-anchored independent intracellular signaling resulting in [Ca2+]i elevation, ERK1, ERK2 and CREB phosphorylation, and Src family kinase activation are described, as well as methods for treatment involving administration of agonists/antagonists of such signaling.
    Type: Grant
    Filed: October 1, 1999
    Date of Patent: June 14, 2005
    Assignee: Licestia Ltd.
    Inventors: Alexey Vladimirovich Titievsky, Dmitri Poteriaev, Urmas Arumäe, Mart Saarma